Literature DB >> 3904802

Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.

I B Kerr, F D Lee, M Quintanilla, A Balmain.   

Abstract

Study of the distribution of the p21 ras oncogene product as demonstrated by monoclonal antibody Y13-259 shows this protein to be apparently present in all epithelial populations of both premalignant and malignant tumours and throughout the normal foetal and adult epithelial crypt population in the colorectum. Metastatic tumour in liver shows a similar staining pattern which is less intense however than in the surrounding normal hepatocytes. Our results suggest that the presence of this protein is a widespread feature of normal cellular metabolism in certain cell types and is not restricted to those actively involved in cellular proliferation. It appears, furthermore, that neither cells at different stages of carcinogenesis nor those representing variants of a malignant phenotype can be identified using this particular antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904802      PMCID: PMC1977216          DOI: 10.1038/bjc.1985.245

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs.

Authors:  L S Ulsh; T Y Shih
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

3.  Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.

Authors:  M Goyette; C J Petropoulos; P R Shank; N Fausto
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

4.  Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; H A Young; E M Scholnick
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

5.  Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

Authors:  P H Hand; A Thor; D Wunderlich; R Muraro; A Caruso; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

7.  Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.

Authors:  A Thor; P Horan Hand; D Wunderlich; A Caruso; R Muraro; J Schlom
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

8.  Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; I Pastan; T Y Shih; E M Scolnick
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

Review 9.  Transforming ras oncogenes and multistage carcinogenesis.

Authors:  A Balmain
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

Review 10.  The 1984 Walter Hubert lecture. Activation of transforming genes in neoplasms.

Authors:  G M Cooper
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

View more
  9 in total

1.  Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.

Authors:  A K Ghosh; M Moore; M Harris
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.

Authors:  P G Chesa; W J Rettig; M R Melamed; L J Old; H L Niman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.

Authors:  D C Allen; H Foster; J C Orchin; J D Biggart
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

4.  Enhanced expression of ras gene products in psoriatic epidermis.

Authors:  H Kobayashi; H Yasuda; A Ohkawara; H Dosaka; A Oda; Y Ogiso; N Kuzumaki
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 5.  Do all colorectal carcinomas arise in preexisting adenomas?

Authors:  J R Jass
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

6.  Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas.

Authors:  Z M Sheng; M Barrois; J Klijanienko; C Micheau; J M Richard; G Riou
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Reactivity of monoclonal antibodies to oncoproteins with normal rat liver, carcinogen-induced tumours, and premalignant liver lesions.

Authors:  M J Embleton; P C Butler
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

8.  The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma.

Authors:  I B Kerr; D A Spandidos; I G Finlay; F D Lee; C S McArdle
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

9.  Elevated production of growth factor by human premalignant colon adenomas and a derived epithelial cell line.

Authors:  C B Wigley; C Paraskeva; R Coventry
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.